Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 27

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 27
---
Our Board of Directors has determined that each member of our Compensation Committee is independent for such purposes within the meaning of the listing rules of Nasdaq. We believe that the composition of our Compensation Committee meets the requirements for independence under, and the functioning of our Compensation Committee complies with, all applicable requirements of Nasdaq and SEC rules and regulations.

#### Corporate Governance and Nominating Committee
Our Corporate Governance and Nominating Committee oversees and assists our Board of Directors in reviewing and recommending corporate governance policies and nominees for election to our Board of Directors. The Corporate Governance and Nominating Committee is responsible for, among other things:

• reviewing and assessing and making recommendations to our Board of Directors regarding desired qualifications, expertise and characteristics sought of board members;

• establishing procedures for the submission of candidates for election to our Board of Directors;

• reviewing our succession planning process for our Chief Executive Officer and other members of our executive management team;

• reviewing the structure and composition of each committee of our Board of Directors;

• reviewing and making recommendations to our Board of Directors regarding our corporate governance guidelines and corporate governance framework;

• overseeing director orientation for new directors and continuing education for our directors;

• reviewing and discussing with management enterprise risk, including cybersecurity risks;

• overseeing the evaluation of the performance of our Board of Directors and its committees;

• reviewing conflicts of interest of our board members and officers other than related party transactions reviewed by our Audit Committee;

• administering policies and procedures for communications with the non-management members of our Board of Directors; and

• reviewing and discussing with management the disclosure of the Company’s corporate governance practices.

| 2025 Proxy Statement |     | 20 |

TABLE OF CONTENTS

Our Board of Directors has determined that each member of our Corporate Governance and Nominating Committee is independent within the meaning of the listing rules of Nasdaq.

#### Science and Technology Committee
Our Science and Technology Committee oversees and assists our Board of Directors in reviewing relevant science and technology matters related to the Company. The Science and Technology Committee is responsible for, among other things:

• serving in an advisory role and recommending other external advisors to assist us with the use of our science and technology;

• overseeing our innovation strategy, including periodic reviews of our research and development ( “ R&D ” ) portfolio and its overall competitiveness, the science and technology underlying major R&D initiatives, the competitive environment, and disruptive technology impacts;

• periodically conducting targeted reviews of our patent portfolio and strategy;

• advising the Board of Directors on the scientific and R&D aspects of major technology-based transactions and licensing